Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oriveda is a Dutch functional mushroom supplement company and global trademark focused on premium mushroom extracts for consumer health and practitioner use. The company markets itself as a science-oriented seller of well-researched, lab-tested extracts and has operated since 2010 through direct online sales and international logistics. Its portfolio includes extracts such as Lion's Mane, Reishi, Chaga, Cordyceps, Maitake, Turkey Tail/PSP-50, and Agaricus blazei Murrill, as well as blend formulations. Oriveda appears to be a commercial-stage nutraceutical brand rather than a drug-development biotech, with no evident clinical pipeline of regulated therapeutics. Its differentiation centers on extract standardization, quality documentation, and educational content around medicinal mushrooms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oriveda.